BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26306498)

  • 21. Advances in mechanisms of allergic disease in 2016.
    Rothenberg ME; Saito H; Peebles RS
    J Allergy Clin Immunol; 2017 Dec; 140(6):1622-1631. PubMed ID: 29038009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trained innate lymphoid cells in allergic diseases.
    Ebihara T; Tatematsu M; Fuchimukai A; Yamada T; Yamagata K; Takasuga S; Yamada T
    Allergol Int; 2021 Apr; 70(2):174-180. PubMed ID: 33328130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate lymphoid type 2 cells in chronic rhinosinusitis.
    Vreugde S; Wormald PJ
    Curr Opin Allergy Clin Immunol; 2016 Feb; 16(1):7-12. PubMed ID: 26600260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung ILC2s link innate and adaptive responses in allergic inflammation.
    Martinez-Gonzalez I; Steer CA; Takei F
    Trends Immunol; 2015 Mar; 36(3):189-95. PubMed ID: 25704560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Group 2 innate lymphoid cells in lung inflammation.
    Li BW; Hendriks RW
    Immunology; 2013 Nov; 140(3):281-7. PubMed ID: 23866009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New kids on the block: group 2 innate lymphoid cells and type 2 inflammation in the lung.
    Halim TYF; McKenzie ANJ
    Chest; 2013 Nov; 144(5):1681-1686. PubMed ID: 24189861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orchestration between ILC2s and Th2 cells in shaping type 2 immune responses.
    Gurram RK; Zhu J
    Cell Mol Immunol; 2019 Mar; 16(3):225-235. PubMed ID: 30792500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory group 2 innate lymphoid cells.
    Huang Y; Paul WE
    Int Immunol; 2016 Jan; 28(1):23-8. PubMed ID: 26232596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-155 Protects Group 2 Innate Lymphoid Cells From Apoptosis to Promote Type-2 Immunity.
    Knolle MD; Chin SB; Rana BMJ; Englezakis A; Nakagawa R; Fallon PG; Git A; McKenzie ANJ
    Front Immunol; 2018; 9():2232. PubMed ID: 30356668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid mediators as regulators of human ILC2 function in allergic diseases.
    Konya V; Mjösberg J
    Immunol Lett; 2016 Nov; 179():36-42. PubMed ID: 27396531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 2 innate lymphoid cells in the induction and resolution of tissue inflammation.
    Wallrapp A; Riesenfeld SJ; Burkett PR; Kuchroo VK
    Immunol Rev; 2018 Nov; 286(1):53-73. PubMed ID: 30294962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator-activated receptor-γ.
    Batyrova B; Luwaert F; Maravelia P; Miyabayashi Y; Vashist N; Stark JM; Soori SY; Tibbitt CA; Riese P; Coquet JM; Chambers BJ
    Immun Inflamm Dis; 2020 Mar; 8(1):8-23. PubMed ID: 31742928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation.
    Kerscher B; Barlow JL; Rana BM; Jolin HE; Gogoi M; Bartholomew MA; Jhamb D; Pandey A; Tough DF; van Oosterhout AJM; McKenzie ANJ
    Front Immunol; 2019; 10():678. PubMed ID: 31024538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E
    Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
    Front Immunol; 2018; 9():501. PubMed ID: 29593738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-2 is a critical regulator of group 2 innate lymphoid cell function during pulmonary inflammation.
    Roediger B; Kyle R; Tay SS; Mitchell AJ; Bolton HA; Guy TV; Tan SY; Forbes-Blom E; Tong PL; Köller Y; Shklovskaya E; Iwashima M; McCoy KD; Le Gros G; Fazekas de St Groth B; Weninger W
    J Allergy Clin Immunol; 2015 Dec; 136(6):1653-1663.e7. PubMed ID: 26025126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamina propria group 2 innate lymphoid cells impair the antibacterial defense of burned mice to enterococcal translocation.
    Ito I; Bhopale KK; Kobayashi M; Finnerty CC; Herndon DN; Suzuki F
    J Leukoc Biol; 2017 Dec; 102(6):1451-1460. PubMed ID: 28951418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barrier Epithelial Cells and the Control of Type 2 Immunity.
    Hammad H; Lambrecht BN
    Immunity; 2015 Jul; 43(1):29-40. PubMed ID: 26200011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation.
    Mortaz E; Amani S; Mumby S; Adcock IM; Movassaghi M; Folkerts J; Garssen J; Folkerts G
    J Immunol Res; 2018; 2018():2785971. PubMed ID: 30510964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory Arthritis and Bone Metabolism Regulated by Type 2 Innate and Adaptive Immunity.
    Omata Y; Frech M; Saito T; Schett G; Zaiss MM; Tanaka S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.